Williams RD - Search Results

1

Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain.

Menda Y, Bushnell DL, Williams RD, Miller S, Thomas MO. Menda Y, et al. Among authors: williams rd. Clin Nucl Med. 2000 Sep;25(9):698-700. doi: 10.1097/00003072-200009000-00009. Clin Nucl Med. 2000. PMID: 10983757 Clinical Trial.

2

Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents.

Bushnell DL, Madsen M, Kahn D, Nathan M, Williams RD. Bushnell DL, et al. Among authors: williams rd. Nucl Med Commun. 1999 Oct;20(10):875-81. doi: 10.1097/00006231-199910000-00002. Nucl Med Commun. 1999. PMID: 10528290 Clinical Trial.

3

A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy.

Kahn D, Austin JC, Maguire RT, Miller SJ, Gerstbrein J, Williams RD. Kahn D, et al. Among authors: williams rd. Cancer Biother Radiopharm. 1999 Apr;14(2):99-111. doi: 10.1089/cbr.1999.14.99. Cancer Biother Radiopharm. 1999. PMID: 10850293 Clinical Trial.

4

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence.

Kahn D, Williams RD, Seldin DW, Libertino JA, Hirschhorn M, Dreicer R, Weiner GJ, Bushnell D, Gulfo J. Kahn D, et al. Among authors: williams rd. J Urol. 1994 Nov;152(5 Pt 1):1490-5. doi: 10.1016/s0022-5347(17)32453-9. J Urol. 1994. PMID: 7523704 Clinical Trial.

5

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.

Kahn D, Williams RD, Haseman MK, Reed NL, Miller SJ, Gerstbrein J. Kahn D, et al. Among authors: williams rd. J Clin Oncol. 1998 Jan;16(1):284-9. doi: 10.1200/JCO.1998.16.1.284. J Clin Oncol. 1998. PMID: 9440754

6

Magnetic resonance imaging for detection of prostate cancer metastatic to bone.

Turner JW, Hawes DR, Williams RD. Turner JW, et al. Among authors: williams rd. J Urol. 1993 Jun;149(6):1482-4. doi: 10.1016/s0022-5347(17)36422-4. J Urol. 1993. PMID: 8501793

7

Management of prostate and bladder cancer in the elderly.

Dreicer R, Cooper CS, Williams RD. Dreicer R, et al. Among authors: williams rd. Urol Clin North Am. 1996 Feb;23(1):87-97. doi: 10.1016/s0094-0143(05)70295-0. Urol Clin North Am. 1996. PMID: 8677539 Review.

8

Phase II trial of 5-fluorouracil and alpha-2b interferon in patients with hormone-refractory metastatic prostate cancer.

Dreicer R, Forest PK, Williams RD. Dreicer R, et al. Among authors: williams rd. Urology. 1994 Sep;44(3):377-80. doi: 10.1016/s0090-4295(94)80096-0. Urology. 1994. PMID: 7521094 Clinical Trial.

9

Incidence of surgical margin involvement in various forms of radical prostatectomy.

Wahle S, Reznicek M, Fallon B, Platz C, Williams R. Wahle S, et al. Urology. 1990 Jul;36(1):23-6. doi: 10.1016/0090-4295(90)80306-8. Urology. 1990. PMID: 2368227

10

Laparoscopic pelvic lymph node dissection following definitive radiotherapy for carcinoma of the prostate.

Lund GO, Winfield HN, Donovan JF, See WA, Loening SA, Williams RD. Lund GO, et al. Among authors: williams rd. J Urol. 1997 Feb;157(2):548-51. J Urol. 1997. PMID: 8996353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters